Ketamine and chronic treatment-resistant depression: real-world practice and after relapse
Introducing rapid-acting antidepressant to manage TRD patients in clinical practice demands further investigation, and the benefit-to-harm ratio should be assessed in the light of the increased risk of suicidality.
Authors
- Youssef Latifeh (ORCID: https://orcid.org/0000-0003-2832-1212)
- L. Youssef (ORCID: https://orcid.org/0000-0002-0554-5507)
- Sumaya Jobnah
- Dina Al Kabani
Institutions
- Damascus University (SY)
Publication Details
- Journal
- BMC Psychiatry
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1186/s12888-024-06203-2
- Citations
- 1
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 0.45